0 followers
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline target... Read more
Jacob Chacko
ALS Therapy Development Institute
3 followers
Cosette Pharmaceuticals
1 follower
Pfizer
519 followers
Azurity Pharmaceuticals
6 followers
Summit Therapeutics
4 followers
Atomica
1 follower
Pivot Bio
2 followers
Generation Bio
2 followers
Abbott
294 followers
Focus Staff
17 followers
Merck
228 followers
Explore companies